Ryvu Therapeutics S.A announced a private placement of ?20 million in an equity round of funding on November 30, 2022. The transaction include participation from BioNTech SE.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
88.98 USD | +1.17% | +0.57% | -15.68% |
Apr. 25 | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
Apr. 25 | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
88.98 USD | +1.17% | +0.57% | 21.2B | ||
49.5 PLN | +1.33% | -2.56% | 280M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.68% | 21.2B | |
-3.16% | 102B | |
+1.46% | 96.29B | |
+2.13% | 22.18B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.46% | 16.36B | |
+4.52% | 13.97B | |
+32.18% | 12.17B | |
+327.54% | 8.32B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- Ryvu Therapeutics S.A. announced that it expects to receive ?20 million in funding from BioNTech SE